Get 40% Off
🔥 This hedge fund gained 26.16% in the last month. Get their top stocks with our free stock ideas tool.See stock ideas

Veeva Systems Announces New DAM Solution For Life Sciences

Published 12/05/2018, 09:52 PM
Updated 07/09/2023, 06:31 AM
US500
-
AAPL
-
AMZN
-
ILMN
-
QDEL
-
STAA
-
VEEV
-

Veeva Systems (NYSE:VEEV) recently introduced Veeva Vault Digital Publishing, a digital asset management (“DAM”) solution for life sciences companies. The platform allows users to update digital content using Vault PromoMats or Vault MedComms to any channel.

Vault Digital Publishing is expected to be available by the end of 2018.

Per management, this DAM solution provides an innovative way for the life sciences companies to publish or withdraw any digital channel. The platform leverages on Amazon (NASDAQ:AMZN) CloudFront.

What is DAM?

DAM is a business phenomenon used for organizing rich media, which includes photos, music, videos, animations, podcasts and other multimedia content. It is also used for managing digital rights and permissions.

Per Markets And Markets, the DAM market is projected to see a CAGR of 18.3% from $2.44 billion in 2017 to $5.66 Billion in 2022. Given the strong prospects, Veeva Systems’ latest initiative is likely to provide it with a competitive edge in the niche space.

For investors’ notice, apart from Vault Digital Publishing, Veeva Vault PromoMats is also a DAM capability that helps brand managers create portals, and organize and showcase digital content. Recently, Veeva Vault PromoMats was adopted by Roche, a research-based healthcare company.

Shares Up

Veeva Systems has outperformed its industry in a year’s time. The stock has rallied 61% compared with the industry’s 6.6% growth. The current level also compares favorably with the S&P 500's return of 2.8%.

Growing demand for cloud-based vault applications, product launches, an industry-focus approach, need-oriented products and international expansion are key drivers for Veeva Systems. The stock has a Zacks Rank #1 (Strong Buy).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Veeva Systems Inc. Price and Consensus

Products Portfolio Strong

Veeva Systems’ industry-specific focus gives it a significant leverage. The company recently introduced Veeva Nitro, a next-generation commercial data warehouse for the life sciences industry. Veeva Systems has also released its advanced Veeva Commercial Cloud offering and Veeva CRM Engage Webinar.

Veeva Systems’ unique solutions include Veeva Vault, Veeva CRM, Veeva Network and VeevaOpenData. Veeva Vault is the first cloud-based content management system built specifically for the life sciences. Veeva CRM is a customer relationship management platform that offers cloud-based solutions to reach customers on any channel.

Another new cloud application of the company is Veeva Vault Training, designed to simplify role-based training across life sciences organizations and help quality teams remain audit-ready and compliant.

Other Key Picks

Other top-ranked stocks in the broader medical space are Quidel Corporation (NASDAQ:QDEL) , STAAR Surgical Company (NASDAQ:STAA) and Illumina, Inc. (NASDAQ:ILMN) .

Quidel Corporation has long-term expected earnings growth rate of 25% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.

With a Zacks Rank #1, STAAR Surgical delivered average four-quarter positive earnings surprise of 400%.

Illumina’s long-term earnings growth rate is projected at 23.4%. The stock carries a Zacks Rank of 2 (Buy).

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple (NASDAQ:AAPL) sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.

Click here for the 6 trades >>



Veeva Systems Inc. (VEEV): Free Stock Analysis Report

Quidel Corporation (QDEL): Free Stock Analysis Report

Illumina, Inc. (ILMN): Free Stock Analysis Report

STAAR Surgical Company (STAA): Free Stock Analysis Report

Original post

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.